Mood Disorders Summit 2021

Strategies to for evaluation of mental health-related apps, patient privacy, and informed decision-making.

John Torous, MD Released: September 2, 2021

Strategies to managing the bipolar depressive spectrum.

Roger McIntyre, MD, FRCPC Released: August 31, 2021

Strategies in the current controversies in mood disorders.

Sanjay J. Mathew, MD Released: August 31, 2021

Strategies in the current controversies in mood disorders, part 2.

Joseph F. Goldberg, MD Released: August 31, 2021

Strategies in the role of inflammation in the etiology, diagnosis and treatment of mood disorders.

Jennifer Felger, PhD, MSc Released: September 1, 2021

Strategies in implementing measurement-based care in the management of psychiatric illness.

Kurt Kroenke, MD Released: September 2, 2021

Strategies in psychedelics in psychiatry.

Guy Goodwin, FMedSci Released: August 31, 2021

Strategies to improve depression treatment and future directions.

Pim Cuijpers, PhD Released: September 3, 2021

Strategies to improve mood disorders and tardive dyskinesia (TD) treatment.

Greg W. Mattingly, MD Released: September 1, 2021

Strategies to improve treatment-resistant depression from a global perspective.

Siegfried Kasper, MD Released: September 3, 2021

Access this Glossary of Psychiatric Medications for a listing of common antidepressants, typical and atypical antipsychotics, common benzodiazepines, anxiolytics, hypnotics, mood stabilizers and more.

In this interactive recording of a live CCO webinar, Roger McIntyre, MD, FRCPC, discusses components of the bipolar spectrum, diagnostic and screening tools for bipolar disorder, and effective treatment options for bipolar spectrum.

Roger McIntyre, MD, FRCPC Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: December 7, 2021 Expired: December 6, 2022

In this interactive recording of a live CCO webinar, Greg Mattingly, MD, discusses the longitudinal course of psychiatric disorders treated with dopamine receptor–blocking agents, identifies the risk factors for tardive dyskinesia within a mental health practice, reviews how to avoid the pitfalls that could put patients and practice in jeopardy, and notes how to improve quality of life and optimize outcomes in patients with TD.

Greg W. Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: November 22, 2021 Expired: No longer available for credit